Protalix BioTherapeutics to Present Preliminary Data from the BRIGHT Study of pegunigalsidase alfa for the Treatment of Fabry Disease at the 15th Annual WORLDSymposium™ 2019

by NASDAQ Market News January 28, 2019

NASDAQ Market News
Click here to email author

Sensyne Health and the University of Oxford’s Big Data Institute to establish world-leading research alliance using data science and clinical AI for the patient-centred management and treatment of chronic disease

111, Inc. to Collaborate with Lilly in Creating New Solutions for Pharmaceutical Distribution

Ads